These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 323834)

  • 21. Efficacy of metolazone and furosemide in children with furosemide-resistant edema.
    Arnold WC
    Pediatrics; 1984 Nov; 74(5):872-5. PubMed ID: 6493882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metolazone and spironolactone in cirrhosis and the nephrotic syndrome.
    Lang GR; Westenfelder C; Nascimento L; Dhupelia VB; Arruda JA; Kane RE
    Clin Pharmacol Ther; 1977 Feb; 21(2):234-43. PubMed ID: 319937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of diuretic mobilization of cirrhotic ascites by pretreatment fractional sodium excretion.
    Knauf H; Wenk E; Schölmerich J; Goerg KJ; Gerok W; Leser HG; Mutschler E
    Klin Wochenschr; 1990 Jun; 68(11):545-51. PubMed ID: 2198378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation by spironolactone of the magnesiuric effect of acute frusemide administration in patients with liver cirrhosis and ascites.
    Stergiou GS; Mayopoulou-Symvoulidou D; Mountokalakis TD
    Miner Electrolyte Metab; 1993; 19(2):86-90. PubMed ID: 8377729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Furosemide. A clinical evaluation of its diuretic action.
    Stason WB; Cannon PJ; Heinemann HO; Laragh JH
    Circulation; 1966 Nov; 34(5):910-20. PubMed ID: 5332332
    [No Abstract]   [Full Text] [Related]  

  • 26. Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.
    Ward A; Heel RC
    Drugs; 1984 Nov; 28(5):426-64. PubMed ID: 6391889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diuresis in the ascitic patient: a randomized controlled trial of three regimens.
    Fogel MR; Sawhney VK; Neal EA; Miller RG; Knauer CM; Gregory PB
    J Clin Gastroenterol; 1981; 3 Suppl 1():73-80. PubMed ID: 7035545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pilot randomised double-blind controlled trial of high-dose spironolactone in critically ill patients receiving a frusemide infusion.
    Apte Y; Bellomo R; Warrillow S; Goldsmith D; Gillies M; McGain F
    Crit Care Resusc; 2008 Dec; 10(4):306-11. PubMed ID: 19049481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ratio of urinary potassium to urinary sodium and the potassium and edema status in nephrotic syndrome.
    Matsumoto H; Miyaoka Y; Okada T; Nagaoka Y; Wada T; Gondo A; Esaki S; Hayashi A; Nakao T
    Intern Med; 2011; 50(6):551-5. PubMed ID: 21422677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spironolactone and frusemide in cirrhosis with ascites.
    Sadikali F
    Br J Clin Pract; 1973 Jun; 27(6):222-4. PubMed ID: 4582147
    [No Abstract]   [Full Text] [Related]  

  • 31. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure.
    Pivac N; Rumboldt Z; Sardelić S; Bagatin J; Polić S; Ljutić D; Naranca M; Capkun V
    Int J Clin Pharmacol Res; 1998; 18(3):121-8. PubMed ID: 9825268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diuretic effect and diuretic efficiency after intravenous dosage of frusemide.
    Alván G; Helleday L; Lindholm A; Sanz E; Villén T
    Br J Clin Pharmacol; 1990 Feb; 29(2):215-9. PubMed ID: 2306413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of diuretic measures in hydropic conditions. II. Results in liver cirrhosis].
    Dürr F; Kaufmann W; Horbach L; Michaelis J; Neuhaus GA; Praetorius F
    Klin Wochenschr; 1969 Nov; 47(21):1142-51. PubMed ID: 5382003
    [No Abstract]   [Full Text] [Related]  

  • 34. A comparative study of the diuretic, natriuretic, and kaluretic effects of furosemide when administered at 07:00 h and at 19:00 h.
    Hemal AK; Thind SK; Nath R; Sidhu HK; Sankaranarayanan A; Vaidyanathan S
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):314-6. PubMed ID: 3410608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy and safety of furosemide and a combination of spironolactone and hydrochlorothiazide in congestive heart failure.
    Levy B
    J Clin Pharmacol; 1977 Jul; 17(7):420-30. PubMed ID: 328540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Na+,K+,Cl- cotransport is a marker of distal tubular function in essential hypertension.
    Righetti M; Cusi D; Stella P; Rivera R; Bernardi L; del Vecchio L; Bianchi G
    J Hypertens; 1995 Dec; 13(12 Pt 2):1775-8. PubMed ID: 8903650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma prolactin levels in full-term newborn infants with idiopathic edema: response to furosemide.
    Ertl T; Sulyok E; Bódis J; Csaba IF
    Biol Neonate; 1986; 49(1):15-20. PubMed ID: 3947689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldosterone antagonism studies in the rhesus monkey.
    Hofmann LM; Pedrera HA; Suleymamov OD
    J Pharmacol Exp Ther; 1977 Jul; 202(1):216-20. PubMed ID: 406381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of furosemide oral solution versus furosemide tablets on diuresis and electrolytes in patients with moderate congestive heart failure.
    Cohen N; Golik A; Dishi V; Zaidenstein R; Weissgarten J; Averbukh Z; Modai D
    Miner Electrolyte Metab; 1996; 22(4):248-52. PubMed ID: 8807629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic usefulness of the random urine Na/K ratio in predicting therapeutic response for diuretics in cirrhotic patients with ascites.
    Mohii el SM; El Mansy IM; Salah M; Khedr MA
    J Egypt Soc Parasitol; 2013 Dec; 43(3):767-76. PubMed ID: 24640876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.